Sleep Treatments | Sleep Review
A class action lawsuit has been filed in Massachusetts against Dutch medical technology company Philips to protect consumers harmed by Philips recalled sleep apnea devices, including CPAP and BiPAP machines, as well as ventilators, which increase users’ risk of cancer and can cause other injuries.
Last month, Philips announced a recall of many of its CPAP and BiPAP machines for the treatment of sleep apnea and ventilators for the treatment of respiratory arrest. The recalled products contain polyurethane foam (PE-PUR) based on polyester for sound insulation. It has now become known that the PE-PUR foam can disintegrate and be inhaled or swallowed and can release volatile organic compounds (VOCs), which can lead to harmful effects on organs and cancer.
In a note to doctors, Philips said that these hazards could lead to “serious injury that could be life-threatening or cause permanent impairment”. In particular, Philips stated that it “has received reports of possible patient effects from foam degradation. Potential risks from particle exposure include headache, irritation, inflammation, breathing problems, and possible toxic and carcinogenic effects. Potential risks of chemical exposure due to outgassing include headache, irritation, hypersensitivity, nausea / vomiting, and possible toxic and carcinogenic effects. “
[RELATED: Sleep Professionals Scramble to Find Solutions for Sleep Apnea Patients Amidst Philips Device Recall]
The complaint alleges that Philips was aware of these significant and material risks in its CPAP devices long before the recall. The complaint also alleges that patients using the affected devices have complained to Philips about black particles in their devices for many years, but Philips did not warn the public of the dangers until late April and did not call its devices until Jan.
“This major class action lawsuit seeks to have any harm suffered by consumers who have purchased the recalled CPAP devices and have Philips replace them with safe and effective devices free of charge,” said Shanon Carson, plaintiff’s attorney and executive director Berger Montague shareholders in a statement. “Our customers and the many patients who have contacted us shouldn’t have to deal with finding that they have inhaled harmful volatile organic compounds. It is outrageous and we look forward to fighting on your behalf to reach a solution with Philips that will provide compensation for your economic and personal harm. “